| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cancer Research | 120 / 233 | 48th | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tumor Biology
Tumor Biology is Scopus-indexed (Q3, CiteScore 5.3), DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1010-4283Verify ISSN ↗1423-0380Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Tumor Biology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1985–present, best quartile Q3, CiteScore 5.3.
What quartile is Tumor Biology in Scopus?
Tumor Biology is Q3 in Cancer Research (rank 120 of 233), by CiteScore 2025.
What is the impact factor of Tumor Biology?
Tumor Biology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 5.3, quartile Q3, 48th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.802, quartile Q2, with an H-index of 111.
How much does it cost to publish in Tumor Biology?
The publisher lists an article processing charge of about US$2,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Tumor Biology and what is its ISSN?
Tumor Biology is published by SAGE Publications Ltd. Its print ISSN is 1010-4283 and its online ISSN is 1423-0380.
Is Tumor Biology in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Tumor Biology open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Tumor Biology? — open metrics via OpenAlex
Tumor Biology has an h-index of 123 and a 2-year mean of 3 citations per paper (OpenAlex). Its Scopus CiteScore is 5.3, quartile Q3. On 2-year citations it ranks #95 of 229 Scopus journals in Cancer Research.
Tumor Biology published 7 papers in 2025; its busiest recent year was 2019 with 1,124. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Tumor Biology? — latest 74 articles, 2021–2026
In its latest 74 research articles (2021–2026), authors are most often from Germany (12.8%), United States (10.4%) and Netherlands (9.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Tumor Biology? — indicators, not proof of misconduct
Scopus status: Active. 233 retracted papers are recorded (26.8 per 1,000 papers). The Problematic Paper Screener flags 19 of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 233 · 26.8 per 1,000 papers
- Problematic Paper Screener flags 19 · 2.2 per 1,000 papers — mostly suspect text and wrongly identified sequences
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.